Navigation Links
Ventana Supports World Patient Safety Day, July 25

TUCSON, Ariz., July 17, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, will join thousands of patients, families, providers, and consumer groups worldwide in observing World Patient Safety Day on July 25 in tribute to those who work to improve the safety and quality of healthcare, and in memory of patients and families who have suffered from medical error.


A Southern Arizona-based supplier of automated diagnostic instrumentation and advanced tests, Ventana was established 25 years ago to improve the lives of all patients afflicted with cancer through scientific excellence and a relentless focus on innovation.

Watch the video: Ventana's Patient Safety Initiative.

"The spirit of this global initiative – to offer hope, healing and advocacy for safe healthcare, to save lives and to reduce healthcare costs through the elimination of preventable medical errors– is embodied in our Ventana mission to improve the lives of all patients afflicted with cancer," says Mara G. Aspinall, President, Ventana Medical Systems, Inc.

"As a global leader in helping hospitals, cancer centers, and laboratories worldwide improve patient care, Ventana salutes the organizers of World Patient Safety Day and supports their efforts to increase awareness of the vital importance of timely, accurate diagnosis and optimal treatment for every patient."

The Ventana portfolio of instruments and reagents not only provides accurate and speedy delivery of diagnostic results but also minimizes the risk of patient misidentification caused by mislabeling or tissue cross contamination.

About Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company's intuitive, integrated staining, workflow management platforms, and digital pathology solutions optimize laboratory efficiencies to reduce errors, support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving Personalized Healthcare through accelerated drug discovery and the development of "companion diagnostics" to identify the patients most likely to respond favorably to specific therapies. Visit to learn more.

CONTACT: Jacqueline Bucher, Senior Director, Corporate Communications, +1-520-877-7288,


SOURCE Ventana Medical Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
2. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
3. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
4. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
5. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
6. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
7. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
8. Misonix Exhibits at Major Worldwide Spine Conference
9. Sony Announces Worlds First Medical-Grade Monitor Utilizing Breakthrough OLED Technology
10. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
11. World Wound Care Markets (Skin Ulcer, Burns, Surgical/Trauma)
Post Your Comments:
(Date:11/27/2015)... DUBLIN , Nov. 27, 2015 Research ... of the "Global Intrauterine Devices Market 2015-2019" ... --> In this report, the author ... intrauterine devices market for 2015-2019. To calculate the market ... of following type of products: Hormonal IUDs and copper ...
(Date:11/26/2015)... november 2015 AAIPharma Services Corp./Cambridge ... investering aan van ten minste $15,8 miljoen ... het mondiale hoofdkantoor in Wilmington, ... in extra kantoorruimte en extra capaciteit voor ... behoeften van de farmaceutische en biotechnologische markten. ...
(Date:11/26/2015)... Research and Markets ( ) has announced ... Outlook to 2019 - Rise in Cardiac Disorders and Growing ... to their offering. Boston ... scientific and others. --> The market ... Boston scientific and others. ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... ... progress through sharing, the 2016 Building Better Radiology Marketing Programs meeting ... begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas with ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, ... interesting show that delves into an array of issues that are presently affecting Americans. ... from open dialogue, this show is changing the subjects consumers focus on, one episode ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... an innovative online platform for mental health and wellness consultation, has collaborated with ... partnership will bridge the knowledge gap experienced by parents and bring advice from ...
(Date:11/27/2015)... IL (PRWEB) , ... November 27, 2015 , ... ... of the largest, most successful and prominent nonprofit healthcare organizations in the country. ... governance involvement with various organizations, and helped advance the healthcare industry as a ...
(Date:11/27/2015)... Francisco, California (PRWEB) , ... November 27, 2015 , ... ... Janis Joplin Ann Arbor Michigan boxing style concert posters. This is one of Joplin's ... at the Canterbury House at the University of Michigan in Ann Arbor. The According ...
Breaking Medicine News(10 mins):